Literature DB >> 7953597

The pathogenesis of gait hypokinesia in Parkinson's disease.

M E Morris1, R Iansek, T A Matyas, J J Summers.   

Abstract

To identify the fundamental deficit in gait hypokinesia in Parkinson's disease (PD) we conducted a series of experiments that compared PD subjects with age- and height-matched controls in their capacity to regulate either stride length, cadence (steps per minute) or both parameters to three conditions. In the first condition the spatial and temporal parameters of gait were documented for slow, normal and fast walking. The second condition compared parkinsonian gait with the walking pattern of elderly controls whilst controlling for two movement speeds: fast (control preferred) speed and slow (PD preferred) speed. In the third condition we examined the ability of PD subjects to regulate one parameter (e.g. stride length) when the other two parameters (e.g. velocity and cadence) were held at control values. A total of 34 PD subjects and 34 matched controls were tested using a footswitch stride analysis system that measured the spatial and temporal parameters of gait for a series of 10 m walking trials. Parkinsonian subjects exhibited marked gait hypokinesia in each of the experiments. Although they retained the capacity to vary their gait velocity in a similar manner to controls, their range of response was reduced. Within the lower velocity range, PD subjects could vary their speed of walking by adjusting cadence and, to a lesser extent, stride length. However, when the speed of walking was controlled, the stride length was found to be shorter and the cadence higher in PD subjects than in controls. Stride length could not be upgraded by internal control mechanisms in response to a fixed cadence set for age and height-matched velocity. In contrast, cadence was readily modulated by external cues and by internal control mechanisms when stride length was fixed to the values obtained for age- and height-matched controls. It was concluded that regulation of stride length is the fundamental problem in gait hypokinesia and the relative increase in cadence exhibited by PD subjects is a compensatory mechanism for the difficulty in regulating stride length. These findings are discussed in the context of the hypothesized role of the basal ganglia in generating internal cues for the maintenance of the gait sequence and in relation to the structuring of movement rehabilitation strategies.

Entities:  

Mesh:

Year:  1994        PMID: 7953597     DOI: 10.1093/brain/117.5.1169

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  147 in total

1.  Comparative analysis of the gait disorder of normal pressure hydrocephalus and Parkinson's disease.

Authors:  H Stolze; J P Kuhtz-Buschbeck; H Drücke; K Jöhnk; M Illert; G Deuschl
Journal:  J Neurol Neurosurg Psychiatry       Date:  2001-03       Impact factor: 10.154

2.  Effects of levodopa on forward and backward gait patterns in persons with Parkinson's disease.

Authors:  M S Bryant; D H Rintala; J G Hou; E C Lai; E J Protas
Journal:  NeuroRehabilitation       Date:  2011       Impact factor: 2.138

3.  Basic parameters of articulatory movements and acoustics in individuals with Parkinson's disease.

Authors:  Bridget Walsh; Anne Smith
Journal:  Mov Disord       Date:  2012-01-04       Impact factor: 10.338

4.  Characteristics of the electromyographic patterns of lower limb muscles during gait in patients with Parkinson's disease when OFF and ON L-Dopa treatment.

Authors:  M Cioni; C L Richards; F Malouin; P J Bedard; R Lemieux
Journal:  Ital J Neurol Sci       Date:  1997-08

5.  Gait asymmetry in patients with Parkinson's disease and elderly fallers: when does the bilateral coordination of gait require attention?

Authors:  Galit Yogev; Meir Plotnik; Chava Peretz; Nir Giladi; Jeffrey M Hausdorff
Journal:  Exp Brain Res       Date:  2007-03       Impact factor: 1.972

6.  Gait quantitation in Parkinson's disease--locomotor disability and correlation to clinical rating scales.

Authors:  P Vieregge; H Stolze; C Klein; I Heberlein
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

Review 7.  Gait dynamics, fractals and falls: finding meaning in the stride-to-stride fluctuations of human walking.

Authors:  Jeffrey M Hausdorff
Journal:  Hum Mov Sci       Date:  2007-07-05       Impact factor: 2.161

Review 8.  Mesencephalic and extramesencephalic dopaminergic systems in Parkinson's disease.

Authors:  Fanni F Geibl; Martin T Henrich; Wolfgang H Oertel
Journal:  J Neural Transm (Vienna)       Date:  2019-01-14       Impact factor: 3.575

9.  Oxygen cost of over-ground walking in persons with mild-to-moderate Parkinson's disease.

Authors:  Brenda Jeng; Katie L J Cederberg; Byron Lai; Jeffer E Sasaki; Marcas M Bamman; Robert W Motl
Journal:  Gait Posture       Date:  2020-08-11       Impact factor: 2.840

10.  Walking economy in people with Parkinson's disease.

Authors:  Cory L Christiansen; Margaret L Schenkman; Kim McFann; Pamela Wolfe; Wendy M Kohrt
Journal:  Mov Disord       Date:  2009-07-30       Impact factor: 10.338

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.